Epix Medical, Dyax deal

The companies will develop contrast imaging agents to diagnose severe blood

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE